09.03.2011 • NewsStyronDow spinoff StyronStyron IPO

Styron Planning IPO

Styron Planning IPO

Plastics company Styron is planning an initial public offering less than nine months since private equity firm Bain Capital bought it from Dow Chemical, two sources familiar with the situation said on Tuesday.

The lead underwriters on the IPO are expected to be chosen in the next few weeks, one of the sources said.

The sources cautioned that the details are preliminary and could change. The information is not public and the sources declined to be named.

A Styron IPO would be an unusually quick exit for Bain, as it and other buyout firms tend to hold investments for at least a few years.
Dow announced the $1.63 billion sale of its Styron basic plastics unit to Bain in March last year, and the deal closed in June.
Styron was not immediately available for comment, while Bain declined to comment.

Company

Styron

2030 Dow Center
48674-0001 Midland

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.